The Purse Podcast

There are a handful of genuinely useful fundraising mechanics discussed (advanced subscription agreements to fund hires, rolling closes, deliberately reformulating raise size to close faster, the 'platform' language shift changing investor perception) but these are heavily diluted by motivational filler, mutual affirmation, and generic resilience advice. Insight-per-minute is low.

“I think I just need to stop fundraising because it takes so much time and energy, so I need to just get to work and get to that next inflection point, get to the next milestone”

“I started actually using the word platform...people automatically got it. And I was like, okay, I've just been being really stupid”

The strategic pivot from manufacturing to IP licensing and the observation that reformulating the raise size downward to accelerate closes are modestly fresh. However, gender bias in fundraising, the importance of resilience, and 'finding the right investors' are heavily recycled themes with no genuinely contrarian or first-principles framing offered.

“male founders typically really over egg what they're the projections, if you will...and female founders typically do the complete opposite”

“if a job doesn't want me because I have tattoos, then so be it. It's not the right fit. And so I think the way that I've reasoned it in my mind is that for whatever reason they said no...it obviously was not the right fit”

Georgia Fleet is a genuine practitioner - she founded the company, made a significant business model pivot, navigated a messy multi-close seed round, and has first-hand commercialisation experience in medtech. However, she is two years in with a $2.1M seed at time of recording, limiting the depth of scaled operational experience she can draw on.

“we actually started off with the business model of we're going to manufacture this...And then we had a massive pivot, basically”

“we reformulated the raise to be like, okay, let's get to a million, and then close it. So we did that”

There are some useful concrete details - the $2.1M total raise, ASAs, the Angel Academy and Thena Capital named leads, a reformulated $1M intermediate target, and specific device categories (IV lines, central lines, ET tubes, urinary catheters). However, no clinical efficacy data, no market size figures, no infection rate statistics, and the Harvard Business Review study on founder questioning is referenced only vaguely without citation.

“the total was the 2.1 million, but we'd been raising this, I think, over the span of a year”

“we had another close that was led by Thena Capital, which was where the bulk of that 2.1 million then came in”

The host asks broadly relevant questions but repeatedly validates answers with 'amazing,' 'wonderful,' and 'isn't that always the way' without probing claims, requesting data, or introducing any productive tension. Follow-up questions largely restate what the guest just said rather than pushing deeper, making this feel like a friendly profile rather than a rigorous interview.

“Amazing. Isn't that always the way that you start delving into an area that you find interesting? You do research, you having to think through what everyone else has developed”

“That's amazing. Incredible. Now people see the headline announcing the 2.1 million seed round”